- Home
- CCG vs CRVO Comparison
CCG vs CRVO Comparison
Compare CCG & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- CRVO
- Stock Information
- Founded
- CCG 2014
- CRVO 2001
- Country
- CCG China
- CRVO United States
- Employees
- CCG N/A
- CRVO N/A
- Industry
- CCG
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- CRVO Health Care
- Exchange
- CCG Nasdaq
- CRVO Nasdaq
- Market Cap
- CCG 68.6M
- CRVO 69.3M
- IPO Year
- CCG N/A
- CRVO N/A
- Fundamental
- Price
- CCG $0.82
- CRVO $7.22
- Analyst Decision
- CCG
- CRVO Strong Buy
- Analyst Count
- CCG 0
- CRVO 8
- Target Price
- CCG N/A
- CRVO $25.57
- AVG Volume (30 Days)
- CCG 170.1K
- CRVO 234.7K
- Earning Date
- CCG 06-06-2025
- CRVO 05-12-2025
- Dividend Yield
- CCG N/A
- CRVO N/A
- EPS Growth
- CCG N/A
- CRVO N/A
- EPS
- CCG N/A
- CRVO N/A
- Revenue
- CCG $475,831,129.00
- CRVO $9,308,215.00
- Revenue This Year
- CCG N/A
- CRVO N/A
- Revenue Next Year
- CCG $7.06
- CRVO N/A
- P/E Ratio
- CCG N/A
- CRVO N/A
- Revenue Growth
- CCG 5.20
- CRVO 15.14
- 52 Week Low
- CCG $0.56
- CRVO $1.80
- 52 Week High
- CCG $1.57
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- CCG 46.18
- CRVO 35.85
- Support Level
- CCG $0.78
- CRVO $7.51
- Resistance Level
- CCG $0.84
- CRVO $8.59
- Average True Range (ATR)
- CCG 0.03
- CRVO 0.50
- MACD
- CCG 0.00
- CRVO -0.17
- Stochastic Oscillator
- CCG 48.20
- CRVO 8.40
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.